Free Trial

Biotricity Q4 2024 Earnings Report

Biotricity logo
$0.28 -0.01 (-4.08%)
(As of 12/20/2024 05:55 PM ET)

Biotricity EPS Results

Actual EPS
-$0.47
Consensus EPS
-$0.36
Beat/Miss
Missed by -$0.11
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$3.18 million
Expected Revenue
$3.20 million
Beat/Miss
Missed by -$20.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Q4 2024
Time
N/A

Conference Call Resources

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Biotricity Earnings Headlines

Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.
Biotricity Inc BTCY
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (OTCMKTS:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat

Upcoming Earnings